JYSB1900289 | Atezolizumab注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2019-10-15 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2019-10-14 | view |
JYSB1900100 | Atezolizumab注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2019-05-13 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2019-05-10 | view |
JYSB1700159 | Atezolizumab注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2017-09-11 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2017-11-23 | view |
JYSB1700025 | MPDL3280A注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2017-03-15 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2017-05-16 | view |
JYSB1700013 | MPDL3280A注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2017-02-15 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2017-04-13 | view |
JYSB1600230 | MPDL3280A注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2016-11-07 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2017-01-10 | view |
JYSB1600205 | MPDL3280A注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2016-10-10 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2017-01-10 | view |
JYSB1600193 | MPDL3280A注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2016-09-14 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2016-11-17 | view |
JYHB1700537 | Alectinib胶囊 | Alectinib Hydrochloride | Capsule | Chemical Drugs | Supplementary Application | 2017-04-20 | F.Hoffmann-La Roche Ltd. | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2017-08-30 | view |
JYHB1601673 | Taselisib片 | taselisib | Tablet | Chemical Drugs | Supplementary Application | 2016-12-19 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2017-05-05 | view |
JXSL2000098 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Import Drug Application | 2020-07-03 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2020-07-02 | view |
JXSL2000088 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Import Drug Application | 2020-07-03 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2020-07-02 | view |
JXSL2000043 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Import Drug Application | 2020-05-11 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2020-05-10 | view |
JXSL1900152 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Import Drug Application | 2019-12-21 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2019-12-20 | view |
JXSL1900151 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Import Drug Application | 2019-12-21 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2019-12-20 | view |
JXSL1900060 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Import Drug Application | 2019-07-22 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2019-07-19 | view |
JXSL1900059 | 输注用Trastuzumab Emtansine浓缩冻干粉 | trastuzumab emtansine | Lyophilized | Biological Products | Import Drug Application | 2019-07-22 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2019-07-19 | view |
JXSL1900058 | 输注用Trastuzumab Emtansine浓缩冻干粉 | trastuzumab emtansine | Lyophilized | Biological Products | Import Drug Application | 2019-07-22 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2019-07-19 | view |
JXSL1900025 | RO7198574 | HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB | Injection | Biological Products | Import Drug Application | 2019-03-11 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2019-03-08 | view |
JXSL1900024 | RO7198574 | HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB | Injection | Biological Products | Import Drug Application | 2019-03-11 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2019-03-08 | view |